hero image
Eliana, actual patient with Dravet syndrome, and Tatiana, her mother and caregiver

Make the DIACOMITment

DIACOMIT® (stiripentol) is an FDA-approved antiseizure medication developed specifically for seizures associated with Dravet syndrome in children as young as 6 months (weighing 15 lb or more) and taking clobazam. It is clinically proven to reduce the frequency and duration of Dravet seizures.1

Learn More About DIACOMIT

Significant Relief From Dravet Seizures With DIACOMIT

We know that finding the right combination of antiseizure treatments for your child is critical. With DIACOMIT (stiripentol), seizure relief is possible, starting as early as 6 months.

homepage infographic
icon
DIACOMIT Study Results

DIACOMIT is proven to significantly reduce generalized clonic or tonic clonic seizures. 1,6-8

Review the Research
icon
Starting on DIACOMIT

DIACOMIT is available in different forms and doses to fit your child’s unique needs.

Get Started
icon
Accessing DIACOMIT

Biocodex is By Your Side, making it easier than ever to fill a prescription for DIACOMIT.

Find Support
img banner Julia, age 7, actual patient on DIACOMIT

Living with Dravet Syndrome

A Dravet syndrome diagnosis is life-changing, and there are resources and communities available to help.

Learn More

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS No contraindications are listed.

WARNINGS & PRECAUTIONSSomnolence DIACOMIT can cause somnolence. Monitor patients for somnolence, particularly when DIACOMIT is used concomitantly with other CNS depressants or clobazam, which is also known to cause somnolence.

Read All